ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
22 announcements with these filters
Aksh Optifibre intimated a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for Q2 and H1 FY27. The letter also notes the company is under CIRP with an IRP supervising operations.
Aksh Optifibre Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Aksh Optifibre held its 39th Annual General Meeting on September 28, 2026, via video conferencing to transact business resolutions, including financial statement adoption.
Mrs. Mona Kailash Choudhari, part of the Promoter Group, sold 134,165 equity shares of Aksh Optifibre Ltd via market sale on September 24, 2026.
Promoter Group member Mrs. Mona Kailash Choudhari sold 93,157 shares of Aksh Optifibre Ltd via market sale for ₹0.07 Crore.
Promoter Dr. Kailash Choudhari sold 69,278 shares of Aksh Optifibre in the open market on 18 September 2026. His holding fell from 1.84% to 1.80%.
Promoter group entity Mrs. Mona Kailash Choudhari sold 69,278 shares of Aksh Optifibre Ltd in an open market transaction.
Aksh Optifibre Limited has issued the notice for its 39th Annual General Meeting scheduled for September 28, 2026, to be held via video conferencing.
Aksh Optifibre submitted its Annual Report and Notice for the 39th Annual General Meeting, which is scheduled for September 28, 2026.
Aksh Optifibre Ltd reported revenue from operations of ₹49.9 Cr (+85.5% YoY) and net profit of ₹4.7 Cr for Q1 FY27.
Aksh Optifibre Limited has scheduled a Board meeting for August 14, 2026, to consider and approve its unaudited financial results for the quarter ending June 30, 2026.
AKSH Optifibre Limited disclosed its shareholding pattern as of June 30 2026. No monetary transaction or financial result is reported.
Aksh Optifibre disclosed an NCLAT order regarding its CIRP. The appellant agreed to deposit ₹2 Crore to maintain operations under IRP supervision.
Aksh Optifibre faces a Section 7 insolvency application filed by Shantanu Investments. The NCLT Jaipur Bench ruled the application maintainable, which the company is challenging.
Aksh Optifibre appointed M/s. Ajay Kumar Singh & Co. as cost auditors and re-appointed internal auditors. Satyendra Kumar Gupta was also re-appointed as a Non-Executive Director.
Aksh Optifibre Ltd reported revenue from operations of ₹40.8 Cr (+23.6% YoY) and net profit of ₹2.2 Cr for Q4 FY26.
Aksh Optifibre reported audited annual standalone and consolidated financial results for the year ended March 31, 2026. The board also re-appointed auditors and directors.
Aksh Optifibre Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms general regulatory adherence with minor prior delays.
Aksh Optifibre scheduled a board meeting on May 28, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-announcement.
Aksh Optifibre Limited confirmed it does not fall under the Large Corporate category for the period ended March 31, 2026. The company reported zero incremental borrowings and no mandatory debt issuance requirements for the 2025-2026 financial year, maintaining compliance with SEBI debt-raising frameworks.
Aksh Optifibre Limited confirmed it does not qualify as a 'Large Corporate' under SEBI's framework for the period ended March 31, 2026. The company reported outstanding borrowings of ₹85.00 Crore. This disclosure is a routine regulatory compliance filing and does not impact immediate operations.
Aksh Optifibre Limited submitted the Regulation 74(5) certificate for the quarter ended March 31, 2026. The certificate, issued by KFin Technologies, confirms that share certificates received for dematerialisation were listed, mutilated, and cancelled as per SEBI guidelines. This is a routine regulatory compliance filing.